A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
Jazz Pharmaceuticals
Astellas Pharma Inc
Eli Lilly and Company
OncoC4, Inc.
Taiho Oncology, Inc.
Revolution Medicines, Inc.
USWM, LLC (dba US WorldMeds)
Ferronova Pty Ltd
Amgen
Arcus Biosciences, Inc.
Seagen Inc.
Qurient Co., Ltd.
Novartis
Legend Biotech USA Inc
NeoTX Therapeutics Ltd.
BeOne Medicines
Immunitas Therapeutics
Sichuan Baili Pharmaceutical Co., Ltd.
Sensei Biotherapeutics, Inc.
OncoC4, Inc.
Tempus AI
Bristol-Myers Squibb
Cybrexa Therapeutics
NextCure, Inc.
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals, Inc
Adaptimmune